Argos Therapeutics, Inc. Announces Filing Of Its Annual Report On Form 10-K

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DURHAM, N.C., April 7, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS) announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC